Home › Targets › KRAS G12C

KRAS G12C (2 companies · 7 programs)

Companies with an active program directed at KRAS G12C.

BridgeBio Oncology Therapeutics, Inc. BBOT

BBO-8520 — Non-Small Cell Lung Cancer Phase 1
BBO-11818 — Non-Small Cell Lung Cancer Phase 1
BBO-11818 — Colorectal Cancer Phase 1
BBO-11818 — Pancreatic Ductal Adenocarcinoma Phase 1

Kura Oncology, Inc. KURA

darlifarnib — Non-Small Cell Lung Cancer Phase 1
darlifarnib — Colorectal Cancer Phase 1
darlifarnib — Pancreatic Ductal Adenocarcinoma Phase 1